Insider trading

Period: 120 months Stock: ANIP + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

241 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

241 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

241 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

241 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
241 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
241 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

241 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
25 Aug 2025
Sold at will
$229.09K 2,528 at 90.62
26.9%
Not planned
22 Aug 2025
Davis Krista SVP, CHIEF HR OFFICER
Sold at will
$160.61K 1,763 at 91.10
2.7%
Not planned
21 Aug 2025
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold at will
$4.79M 52,988 at 90.44
10.9%
Not planned
20 Aug 2025
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold at will
$4.24M 47,012 at 90.27
8.8%
Not planned
20 Aug 2025
Pera Antonio R Director
Sold at will
$486.43K 5,421 at 89.73
15.3%
Not planned
18 Aug 2025
Thoma Jeanne Director
Sold at will 2×
$1.92M 21,540 at 89.15
47.9%
Not planned
18 Aug 2025
Sold at will
$611.64K 6,937 at 88.17
42.5%
Not planned
15 Aug 2025
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold at will
$4.62M 52,990 at 87.15
9.1%
Not planned
15 Aug 2025
Gassert Chad SVP - CORP. DEV. & STRATEGY · indirect
Sold at will
$1.74M 20,000 at 86.97
10.4%
Not planned
15 Aug 2025
Walsh Patrick D Director
Sold at will
$801.45K 9,000 at 89.05
11.4%
Not planned
14 Aug 2025
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold at will
$4.21M 47,010 at 89.48
7.4%
Not planned
13 Aug 2025
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$35.55K 400 at 88.87
0.5%
Planned (10b5-1)
12 Aug 2025
Lalwani Nikhil PRESIDENT & CEO
Sold at will
$4.89M 56,960 at 85.93
12.2%
Not planned
12 Aug 2025
CAREY STEPHEN P. SVP & CFO
Sold at will
$4.30M 50,000 at 86.07
21.7%
Not planned
12 Aug 2025
HAUGHEY THOMAS Director
Sold at will
$1.66M 19,341 at 85.93
34.6%
Not planned
12 Aug 2025
Gutwerg Ori SVP, GENERICS
Sold at will
$508.19K 5,873 at 86.53
6.5%
Not planned
12 Aug 2025
Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS
Sold at will
$426.41K 4,975 at 85.71
10.9%
Not planned
14 Jul 2025
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$25.95K 400 at 64.88
0.5%
Planned (10b5-1)
13 Jun 2025
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$24.55K 400 at 61.37
0.5%
Planned (10b5-1)
15 May 2025
Gutwerg Ori SVP, GENERICS
Sold at will
$52.92K 881 at 60.07
1.0%
Not planned
14 May 2025
Mutz Christopher HEAD OF RARE DISEASE
Sold at will
$241.80K 4,000 at 60.45
3.6%
Not planned
13 May 2025
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$24.88K 400 at 62.20
0.5%
Planned (10b5-1)
9 May 2025
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$53.78K 700 at 76.83
0.1%
Planned (10b5-1)
14 Apr 2025
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$27.58K 400 at 68.96
0.5%
Planned (10b5-1)
19 Mar 2025
Davis Krista SVP, CHIEF HR OFFICER
Sold on a plan
$121.29K 1,866 at 65.00
2.8%
Planned (10b5-1)
13 Mar 2025
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$25.33K 400 at 63.33
0.5%
Planned (10b5-1)
7 Mar 2025
Davis Krista SVP, CHIEF HR OFFICER
Sold on a plan
$60.86K 1,000 at 60.86
1.5%
Planned (10b5-1)
5 Mar 2025
Gutwerg Ori SVP, GENERICS
Sold at will 2×
$323.05K 5,384 at 60.00
5.4%
Not planned
21 Feb 2025
Davis Krista SVP, CHIEF HR OFFICER
Sold on a plan
$60.20K 1,000 at 60.20
1.4%
Planned (10b5-1)
13 Feb 2025
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$23.82K 400 at 59.54
0.5%
Planned (10b5-1)
13 Jan 2025
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$21.57K 400 at 53.92
0.7%
Planned (10b5-1)
17 Dec 2024
CAREY STEPHEN P. SVP & CFO
Sold at will
$418.43K 7,500 at 55.79
4.6%
Not planned
13 Dec 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$14.06K 250 at 56.24
0.4%
Planned (10b5-1)
11 Dec 2024
Davis Krista SVP, CHIEF HR OFFICER
Sold on a plan
$60.00K 1,000 at 60.00
2.0%
Planned (10b5-1)
26 Nov 2024
Lalwani Nikhil PRESIDENT & CEO
Sold at will 2×
$1.94M 33,481 at 57.99
8.3%
Not planned
15 Nov 2024
Mutz Christopher HEAD OF RARE DISEASE
Sold at will
$375.05K 6,500 at 57.70
7.8%
Not planned
13 Nov 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$15.34K 250 at 61.36
0.4%
Planned (10b5-1)
14 Oct 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$14.30K 250 at 57.19
0.4%
Planned (10b5-1)
13 Sep 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$14.21K 250 at 56.82
0.4%
Planned (10b5-1)
13 Aug 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$14.91K 250 at 59.62
0.4%
Planned (10b5-1)
18 Jul 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$170.07K 2,743 at 62.00
0.4%
Planned (10b5-1)
17 Jul 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$900.47K 14,257 at 63.16
2.2%
Planned (10b5-1)
16 Jul 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$1.41M 22,000 at 64.27
3.3%
Planned (10b5-1)
15 Jul 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$697.18K 11,000 at 63.38
1.6%
Planned (10b5-1)
12 Jul 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$16.23K 250 at 64.91
0.4%
Planned (10b5-1)
1 Jul 2024
Gassert Chad SVP - CORP. DEV. & STRATEGY · indirect
Sold on a plan
$1.27M 20,000 at 63.44
9.4%
Planned (10b5-1)
21 Jun 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$1.18M 20,000 at 58.90
2.8%
Planned (10b5-1)
20 Jun 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$685.22K 11,447 at 59.86
1.6%
Planned (10b5-1)
18 Jun 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$644.48K 10,607 at 60.76
1.5%
Planned (10b5-1)
17 Jun 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$487.96K 7,946 at 61.41
1.1%
Planned (10b5-1)
Showing 51–100 of 241. ← Newer Page 2 of 5 Older →